Glucagon-like peptide-1 (GLP-1) is a crucial hormone for the treatment of type II diabetes mellitus, but it is susceptible to rapid inactivation by metabolic enzymes such as dipeptidyl peptidase IV (DPP-IV) and neutral endopeptidase (NEP) under physiological conditions [169]. This evidence concerns the gene GCG and type 2 diabetes mellitus.